228 related articles for article (PubMed ID: 26061320)
1. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
2. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
Magalhães RF; Cruvinel GT; Cintra GF; Cintra ML; Ismael AP; de Moraes AM
J Cutan Med Surg; 2008; 12(4):163-73. PubMed ID: 18627696
[TBL] [Abstract][Full Text] [Related]
4. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
8. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
9. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
10. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
Fernandez-Flores A
Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
[TBL] [Abstract][Full Text] [Related]
11. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
Tran TA; Ross JS; Sheehan CE; Carlson JA
Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
[TBL] [Abstract][Full Text] [Related]
13. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma.
Connolly M; Narayan S; Oxley J; de Berker DA
Clin Exp Dermatol; 2008 Aug; 33(5):625-8. PubMed ID: 18616725
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
Tran TA; Ross JS; Boehm JR; Carlson JA
J Cutan Pathol; 1999 Sep; 26(8):391-7. PubMed ID: 10551411
[TBL] [Abstract][Full Text] [Related]
16. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
17. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
Kaabipour E; Haupt HM; Stern JB; Kanetsky PA; Podolski VF; Martin AM
Arch Pathol Lab Med; 2006 Jan; 130(1):69-73. PubMed ID: 16390241
[TBL] [Abstract][Full Text] [Related]
18. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
19. Assessment of syndecan-1 (CD138) and Ki-67 expression for differentiating keratoacanthoma and squamous cell carcinoma.
Lammoglia-Ordiales L; Toussaint-Caire S; Contreras-Barrera M; Fonte-Avalos V; Rodriguez-Carreón AA; Rivera-Macias S; Dominguez-Cherit J
J Drugs Dermatol; 2013 Mar; 12(3):e53-8. PubMed ID: 23545927
[TBL] [Abstract][Full Text] [Related]
20. Keratoacanthoma, committed stem cells and neoplastic aberrant infundibulogenesis integral to formulating a conceptual model for an infundibulocystic pathway to squamous cell carcinoma.
Kossard S
J Cutan Pathol; 2021 Jan; 48(1):184-191. PubMed ID: 32881028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
